Overuse of antibiotics not only leads to resistance, but may reduce variety of microbes in the gut and affect the immune system’s ability to fight off disease. Research into the role of the gut’s microbiome in infection found that antibiotic use made neutrophils less effective at fighting infections, and may lead to potential treatments or vaccinations.
Overuse of antibiotics not only leads to resistance, but may reduce variety of microbes in the gut and affect the immune system’s ability to fight off disease. Research into the role of the gut’s microbiome in infection found that antibiotic use made neutrophils less effective at fighting infections, and may lead to potential treatments or vaccinations.
A study recently published in PLOS Pathogens investigated the gut microbiome’s role in amebic colitis—a parasitic infection also known as amebiasis that is prevalent in developing countries and can often be deadly—by analyzing the stool samples of children in Dhaka and Bangladesh.
After discovering that children with more severe infections had less diversity in the gut microbiome, the researchers used lab mice to further explore how the natural intestinal flora affects the infection and potentially heightens the disease.
“Neutrophils play an important role as a first-line ‘innate immune response’ when foreign pathogens invade,” researcher Koji Watanabe, PhD, said in a statement. “We found that antibiotic disruption of the natural microbes in the gut prevented this from happening properly, leaving the gut susceptible to severe infection.”
The researchers found that with the use of antibiotics, neutrophils’ activity reduced and white blood cells were blocked from responding when necessary—ultimately resulting in an insufficiently protected gut. The antibiotic’s disruption of the gut also compromised the intestinal barrier that is meant to protect against diseases.
“I think the take-home is that this is another important reason not to use antibiotics unless they are clearly needed,” said researcher Bill Petri, MD, PhD, the chief of UVA’s Division of Infectious Diseases. “Unwise use of antibiotics not only increases the risk of multi-drug resistant bacteria and the risk of C. difficile infection but also impairs white blood cell function.”
The evidence of this study demonstrating the harms of antibiotic treatment and overall importance of the microbiome’s role could prove an important step in developing a vaccine for amebiasis. Although, the researchers noted the need for additional studies to assess the effects of antibiotic use for amebic colitis in a human cohort.
“Demonstration that antibiotics can impair neutrophil chemotaxis to a site of infection may be of broader importance than just amebiasis for the insight that it provides into gut microbiome regulation of the immune system,” the study concluded.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More